By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Prostatype Genomics AB (publ) (PROGEN.ST)

STO Currency in SEK
kr 0.73
-kr 0.03
-3.69%
Last Update: 29 Aug 2025, 15:18
kr 27.01M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
kr 0.50 - kr 27.50
52 Week Range

PROGEN.ST Stock Price Chart

Explore Prostatype Genomics AB (publ) interactive price chart. Choose custom timeframes to analyze PROGEN.ST price movements and trends.

PROGEN.ST Company Profile

Discover essential business fundamentals and corporate details for Prostatype Genomics AB (publ) (PROGEN.ST) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

3 Nov 2020

Employees

6.00

CEO

Fredrik Rickman

Description

Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The test is based on database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision. The company was founded in 2007 and is based in Solna, Sweden.

PROGEN.ST Financial Timeline

Browse a chronological timeline of Prostatype Genomics AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 12 Feb 2025

Stock split effective on 31 Oct 2024

Shares were split 1 : 1000 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 May 2024

Earnings released on 15 Feb 2024

Stock split effective on 8 Dec 2023

Shares were split 1549 : 1000 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 10 Nov 2023

Earnings released on 17 Aug 2023

EPS came in at -kr 0.08 surpassing the estimated -kr 0.10 by +20.00%, while revenue for the quarter reached kr 55.68K , missing expectations by -93.14%.

Earnings released on 31 May 2023

EPS came in at -kr 0.19 , while revenue for the quarter reached kr 388.40K .

Stock split effective on 24 Apr 2023

Shares were split 3007 : 1000 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 16 Feb 2023

EPS came in at -kr 3.60 , while revenue for the quarter reached kr 304.31K .

Earnings released on 10 Nov 2022

EPS came in at -kr 4.24 , while revenue for the quarter reached kr 109.76K .

Earnings released on 18 Aug 2022

EPS came in at -kr 4.93 , while revenue for the quarter reached kr 7.96K .

Stock split effective on 29 Jun 2022

Shares were split 523 : 500 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 12 May 2022

EPS came in at -kr 3.54 , while revenue for the quarter reached kr 260.76K .

Earnings released on 24 Feb 2022

EPS came in at -kr 2.49 .

Earnings released on 31 Dec 2021

EPS came in at -kr 3.67 .

Earnings released on 30 Jun 2021

EPS came in at -kr 1.73 , while revenue for the quarter reached kr 5.00K .

Earnings released on 27 May 2021

Earnings released on 31 Mar 2021

EPS came in at -kr 2.50 , while revenue for the quarter reached kr 5.00K .

PROGEN.ST Stock Performance

Access detailed PROGEN.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run